Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

…, G Ruiz‐Irastorza, MA Khamashta… - Arthritis & …, 2012 - Wiley Online Library
Objective The Systemic Lupus International Collaborating Clinics (SLICC) group revised
and validated the American College of Rheumatology (ACR) systemic lupus erythematosus (…

[PDF][PDF] International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

…, GRV Hughes, DA Triplett, MA Khamashta - … : Official Journal of the …, 1999 - researchgate.net
Preliminary classification criteria for the antiphospholipid syndrome (APS) were formulated
during a post-conference workshop held October 10, 1998 in Sapporo, Japan, following the …

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

…, JC Piette, J Font, MA Khamashta… - … : Official Journal of …, 2002 - Wiley Online Library
Objective To analyze the clinical and immunologic manifestations of antiphospholipid
syndrome (APS) in a large cohort of patients and to define patterns of disease expression. …

[HTML][HTML] The management of thrombosis in the antiphospholipid-antibody syndrome

MA Khamashta, MJ Cuadrado, F Mujic… - … England Journal of …, 1995 - Mass Medical Soc
Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid antibodies. …

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

R Cervera, MA Khamashta, J Font, GD Sebastiani… - Medicine, 2003 - journals.lww.com
In the present study, we assessed the frequency and characteristics of the main causes of
morbidity and mortality in systemic lupus erythematosus (SLE) during a 10-year period and …

The “primary” antiphospholipid syndrome: major clinical and serological features

RA ASHERSON, MA KHAMASHTA, J Ordi-Ros… - Medicine, 1989 - journals.lww.com
ASHERSON, RONALD AMD, FACP, FCP,(SA) 1; KHAMASHTA, MUNTHER AMD 1; ORDI-ROS,
JOSE MD 3; DERKSEN, RONALD HWMMD 2; MACHIN, SAMUEL JMD, FRC PATH. 4; …

Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients

R Cervera, MA Khamashta, J Font, GD SEBASTIANI… - Medicine, 1993 - journals.lww.com
Systemic Lupus Erythematosus: Clinical and Immunologic Patte... : Medicine Systemic Lupus
Erythematosus: Clinical and Immunologic Patterns of Disease Expression in a Cohort of …

Immune-related adverse events of checkpoint inhibitors

…, A Flores-Chávez, N Keegan, MA Khamashta… - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …

Adult haemophagocytic syndrome

…, P Brito-Zerón, A López-Guillermo, MA Khamashta… - The Lancet, 2014 - thelancet.com
Haemophagocytic syndromes (haemophagocytic lymphohistiocytosis) have a wide range of
causes, symptoms, and outcomes, but all lead to a hyperinflammatory response and organ …

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

…, P Brito-Zeron, MA Khamashta - Annals of the …, 2010 - ard.bmj.com
Background: Antimalarial drugs (AMs), chloroquine (CQ) and hydroxychloroquine (HCQ), are
frequently withdrawn in patients with lupus with either severe or remitting disease. However…